These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31102253)

  • 1. BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion.
    Bajaj S; Das AK; Kalra S; Sahay R; Saboo B; Das S; Shunmugavelu M; Jacob J; Priya G; Khandelwal D; Dutta D; Chawla M; Surana V; Tiwaskar M; Joshi A; Shrestha PK; Bhattarai J; Bhowmik B; Latt TS; Aye TT; Vijayakumar G; Baruah M; Jawad F; Unnikrishnan AG; Chowdhury S; Pathan MF; Somasundaram N; Sumanathilaka M; Raza A; Bahendeka SK; Coetzee A; Ruder S; Ramaiya K; Lamptey R; Bavuma C; Shaikh K; Uloko A; Chaudhary S; Abdela AA; Akanov Z; Rodrìguez-Saldaña J; Faradji R; Tiago A; Reja A; Czupryniak L
    Diabetes Ther; 2019 Aug; 10(4):1189-1204. PubMed ID: 31102253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best Practices and Tools for Titrating Basal Insulins: Expert Opinion from an Indian Panel via the Modified Delphi Consensus Method.
    Jain SM; Seshadri K; Unnikrishnan AG; Chawla M; Kalra P; Vipin VP; Ravishankar E; Chordia J; Das S; Wasir J; Bandookwala SM; Deka N; Agarwal G; Vijaykumar G; Erande S
    Diabetes Ther; 2020 Mar; 11(3):621-632. PubMed ID: 32009224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel.
    Chawla M; Jain SM; Kesavadev J; Makkar BM; Viswanathan V; Tiwaskar M; Sosale AR; Negalur V; Modi KD; Gupta M; Kumar S; Ramakrishnan S; Deka N; Roy N
    Diabetes Ther; 2021 Jan; 12(1):133-142. PubMed ID: 33314000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
    Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
    J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".
    Ghosal S; Sinha B; Majumder A; Das AK; Singh AK; Ghoshdastidar B; Maji D; Goyal G; Mukherjee JJ; Gangopadhyay KK; John M; Chatterjee S; Jaggi S; Ray S; Majumdar S; Sharma SK
    J Assoc Physicians India; 2017 Jul; 65(7):51-62. PubMed ID: 28792170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.
    Hong EG; Min KW; Lim JS; Ahn KJ; Ahn CW; Yu JM; Kim HS; Kim HJ; Kim W; Kim DH; Jang HC
    Adv Ther; 2024 May; 41(5):1967-1982. PubMed ID: 38512540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Physician-Led Versus Patient-Led Titration of Insulin Glargine in Indian Patients with Type 2 Diabetes Mellitus: A Subanalysis of the Asian Treat to Target Lantus Study (ATLAS).
    Misra A; Patel M; Agarwal P; Lodha S; Tandon N; Magdum M; Yajnik C; Ghosh R; Walekar A
    Diabetes Technol Ther; 2019 Nov; 21(11):656-664. PubMed ID: 31335198
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
    Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
    Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets.
    Cannon AJ; Bargiota A; Billings L; Hunt B; Leiter LA; Malkin S; Mocarski M; Ranthe MF; Schiffman A; Doshi A
    J Manag Care Spec Pharm; 2020 Feb; 26(2):143-153. PubMed ID: 31856636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
    Lingvay I; Pérez Manghi F; García-Hernández P; Norwood P; Lehmann L; Tarp-Johansen MJ; Buse JB;
    JAMA; 2016 Mar; 315(9):898-907. PubMed ID: 26934259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study).
    Brož J; Janíčková Ždárská D; Štěpánová R; Kvapil M
    Diabetes Ther; 2019 Apr; 10(2):663-672. PubMed ID: 30788806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study.
    Galasso S; Facchinetti A; Bonora BM; Mariano V; Boscari F; Cipponeri E; Maran A; Avogaro A; Fadini GP; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1112-1119. PubMed ID: 27618501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of switching from insulin glargine or detemir to insulin degludec in patients with type 1 diabetes mellitus.
    Kusunoki Y; Katsuno T; Miyakoshi K; Ikawa T; Nakae R; Ochi F; Tokuda M; Akagami T; Murai K; Miuchi M; Hamaguchi T; Miyagawa J; Namba M
    Diabetes Ther; 2013 Dec; 4(2):461-72. PubMed ID: 24282104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study).
    Shimoda S; Sato M; Sekigami T; Motoshima H; Yoshimura R; Fukuda K; Matsuo Y; Noda H; Okubo M; Ichimori S; Fujisawa K; Fukunaga M; Araki E;
    J Diabetes Investig; 2016 Sep; 7(5):703-10. PubMed ID: 27181264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA.
    Hunt B; Mocarski M; Valentine WJ; Langer J
    Adv Ther; 2017 Apr; 34(4):954-965. PubMed ID: 28281218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal Insulin Titration: Moving Towards a More Patient-Centric Approach with Gla-100 in India.
    Madhu SV; Neelaveni K; Pitale S; Somani S; Pandey AK; Kalra P; Ceaser R; Mohanasundaram S; Mohan V
    J Assoc Physicians India; 2020 Dec; 68(12[Special]):38-42. PubMed ID: 33247662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.